Viewing Study NCT06054906


Ignite Creation Date: 2025-12-26 @ 4:04 PM
Ignite Modification Date: 2025-12-29 @ 7:03 AM
Study NCT ID: NCT06054906
Status: RECRUITING
Last Update Posted: 2024-12-30
First Post: 2023-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
Sponsor: Huashan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module